LLY241227P560000
- 0.00
- 0.000.00%
Eli Lilly and Co Newsroom
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
3 Healthcare Stocks to Buy for a 2025 Rebound
Novo-Nordisk A/S faces another blow: Musk shares a weight loss photo, claiming that using Eli Lilly and Co's weight loss drug is more effective than semaglutide.
On Christmas, Musk shared a photo and called himself the Ozempic Santa Claus, clarifying that he didn't mean the drug name Ozempic for semaglutide, but rather Eli Lilly and Co's competitor Mounjaro. He also mentioned that "high doses" of Ozempic would make him fart and burp, adding that "Mounjaro seems to have fewer side effects and is more effective."
Musk revealed that he switched to using Eli Lilly and Co's weight loss medication: the effect is better than Novo-Nordisk A/S's competing products, with fewer side effects.
① The world's richest man Elon Musk confirmed on the Social Media platform X on Wednesday that he is using Eli Lilly and Co's Mounjaro for weight loss; ② Musk revealed that he initially tried using Novo-Nordisk A/S's Ozempic for weight loss, but switched to Mounjaro due to significant side effects.
Jim Cramer Says Eli Lilly and Company (LLY)'s 'Going To Win'
Musk "endorses" Eli Lilly and Co (LLY.US) weight loss drug: Mounjaro has fewer side effects and better results.
On Wednesday, Musk posted on the X platform emphasizing that he prefers Eli Lilly and Co's product Mounjaro over Novo-Nordisk A/S's weight loss treatment Ozempic.
Elon Musk Says He Prefers Lilly's Mounjaro Over Novo's Ozempic
"Nuo Li" weight loss miracle drug mainstreaming brings new challenges in terms of applicability, medical insurance, and more.
GLP-1 is changing the way people view and treat obesity. These changes are happening so quickly that they may benefit many people, leading to new questions and ethical dilemmas for medical professionals, including who should receive medication treatment.
Eli Lilly and Co (LLY) Is Among Billionaire Coleman's Top Picks
Express News | Lilly's weight loss medication is now available for purchase on e-commerce platforms in China
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
Weight-loss Drugs in 2025, Auto Industry Outlook: Market Domination
Eli Lilly's Weight Loss Med Tirzepatide Gets Endorsement From U.K.'s NICE
With EPS Growth And More, Eli Lilly (NYSE:LLY) Makes An Interesting Case
Eli Lilly's Anti-Obesity Drug Mounjaro to Be Supported by UK Public Health System for Some Patients
Sector Update: Health Care Stocks Advance Late Afternoon
Express News | Ely Lilly Shares Are Trading Higher After the FDA Approved the Company's Zepbound, a Weight Loss Drug Designed to Treat Moderate-to-severe Obstructive Sleep Apnea in Adults With Obesity
Eli Lilly Stock Is Rising Monday: What's Going On?
These Stocks Are Moving the Most Today: Honda, Qualcomm, Broadcom, Lilly, ResMed, Tesla, Walmart, Rumble, and More -- Barrons.com
Lilly, Amgen Sue HHS Over Certification of Drug Discount Program Recipients